Condition
Type2 Diabetes Mellitus clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Type2 Diabetes Mellitus clinical trials that are recruiting, at sites in 4 countries (most in China (1), Thailand (1), United States (1)). By phase: Phase 4 (1), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Type2 Diabetes Mellitus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Aleniglipron for adults with overweight/obesity and type 2 diabetes | Phase 3 | Birmingham, Alabama and 73 other locations | Recruiting | Jun 17, 2026 |
| ONO-3310 safety test in healthy men and adults with CKD and type 2 diabetes | Phase 1 | Fukuoka, Fukuoka | Recruiting | Jun 1, 2026 |
| SnapD plus CGM to help adults with type 2 diabetes and overweight manage blood sugar | — | Bangkok, Bangkok | Recruiting | Apr 16, 2026 |
| Effects of Henagliflozein on liver fat in patients with diabetes and fatty liver disease | Phase 4 | Guangzhou, Guangdong | Recruiting | Jun 10, 2024 |
All recruiting trials (4)
-
Aleniglipron for adults with overweight/obesity and type 2 diabetes
A long-term test to see if aleniglipron helps weight loss and blood sugar control in adults who are overweight or obese and have type 2 diabetes.
-
ONO-3310 safety test in healthy men and adults with CKD and type 2 diabetes
This early-phase study tests whether ONO-3310 is safe and well tolerated in healthy Japanese men and in adults with chronic kidney disease and type 2 diabetes, using single and multiple oral doses.
-
SnapD plus CGM to help adults with type 2 diabetes and overweight manage blood sugar
This pilot tests whether SnapD, an AI app that recognizes Thai food, alone or together with a continuous glucose monitor (CGM), can help adults with type 2 diabetes and overweight or obesity lower their blood sugar.
-
Effects of Henagliflozein on liver fat in patients with diabetes and fatty liver disease
This study is testing if a new diabetes medication called Henagliflozein can help reduce liver fat in people with type 2 diabetes and fatty liver disease.
Related topics
Quick answers
How many Type2 Diabetes Mellitus clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (1 trial), Thailand (1 trial), United States (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.